Alsancak, YakupKiziltunc, EmrullahSezenoz, BurakOzkan, SelcukAlsancak, Aybuke DemirGul, MuratCengel, Atiye2025-05-102025-05-1020162149-22632149-227110.14744/AnatolJCardiol.2016.6799https://doi.org/10.14744/AnatolJCardiol.2016.6799https://hdl.handle.net/20.500.14720/15158Ozkan, Selcuk/0000-0003-3613-736X; Roses, Murat/0000-0003-0215-6343Objective: Previous studies have suggested that there is a relationship between coronary artery disease (CAD) and parathyroid hormone (PTH) levels. Here, we aimed to evaluate the association between PTH levels and severity of CAD. Methods: Patients were divided into two groups based on their serum PTH values. Patients with PTH levels = 72 pg/mL were accepted as Group 1 (n=568) and >72 pg/mL as Group 2 (n=87). Gensini score system and > 50% stenosis in any coronary artery with conventional coronary angiography were used to determine the extensiveness of CAD. This study was designed as a prospective and cross-sectional study. Results: Baseline characteristics except for age, gender, and blood pressure were similar between groups. Mean serum PTH levels of the entire cohort was 43.4 +/- 29.5 pg/mL. Median Gensini score was 19.5 in Group 1 and 14.5 in Group 2 (p=0.75). On the other hand, PTH levels were weakly correlated with Gensini score (Spearman's Rho=0.11, p=0.003). Additionally, we did not observe a statistically significant difference between PTH levels and the number of stenotic vessels (p=0.14). This study was designed as a prospective and cross-sectional study. Conclusion: There is no association between serum PTH levels and extensiveness of CAD.eninfo:eu-repo/semantics/openAccessAtherosclerosisCoronary Artery DiseaseParathyroid HormoneGensini ScoreArticle1611Q4Q383984327147401WOS:000392196600008